Placebo Response in Pediatric Anxiety Disorders: Results from the Child/Adolescent Anxiety Multimodal Study
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: The aim of this study is to identify predictors of pill placebo response and to characterize the temporal course of pill placebo response in anxious youth. METHODS: Data from placebo-treated patients (N = 76) in the Child/Adolescent Anxiety Multimodal Study (CAMS), a multisite, randomized controlled trial that examined the efficacy of cognitive-behavioral therapy, sertraline, their combination, and placebo for the treatment of separation, generalized, and social anxiety disorders, were evaluated. Multiple linear regression models identified features associated with placebo response and models were confirmed with leave-one-out cross-validation. The likelihood of improvement in patients receiving pill placebo-over time-relative to improvement associated with active treatment was determined using probabilistic Bayesian analyses. RESULTS: Based on a categorical definition of response (Clinical Global Impressions-Improvement Scale score ≤2), nonresponders (n = 48), and pill placebo responders (n = 18) did not differ in age (p = 0.217), sex (p = 0.980), race (p = 0.743), or primary diagnosis (all ps > 0.659). In terms of change in anxiety symptoms, separation anxiety disorder and treatment expectation were associated with the degree of pill placebo response. Greater probability of placebo-related anxiety symptom improvement was observed early in the course of treatment (baseline to week 4, p < 0.0001). No significant change in the probability of placebo-related improvement was observed after week 4 (weeks 4-8, p = 0.07; weeks 8-12, p = 0.85), whereas the probability of improvement, in general, significantly increased week over week with active treatment. CONCLUSIONS: Pill placebo-related improvement occurs early in the course of treatment and both clinical factors and expectation predict this improvement. Additionally, probabilistic approaches may refine our understanding and prediction of pill placebo response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
BIRMAHER, B., KHETARPAL, S., BRENT, D., CULLY, M., BALACH, L., KAUFMAN, J., & NEER, S. M. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199704000-00018 · Cited by 2,846
Self-citationBIRMAHER, B., BRENT, D. A., CHIAPPETTA, L., BRIDGE, J., MONGA, S., & BAUGHER, M. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199910000-00011 · Cited by 2,252 · cited 2×
“(Birmaher et al. 1997, 1999) Anxious self-talk was assessed with the Negative Affectivity Self-Statement Questionnaire (NASSQ) (Ronan et al. 1994), which consisted of a 70-item self-report that characterizes the frequency of negative effect-related thoughts using a 1–5 Likert scale and has been…”
BackgroundMethodSelf-citationCognitive Behavioral Therapy, Sertraline, or a Combination in Childhood Anxiety
Walkup, J. T., Albano, A. M., Piacentini, J., Birmaher, B., Compton, S. N., Sherrill, J. T., Ginsburg, G. S., Rynn, M. A., McCracken, J., Waslick, B., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804633 · Cited by 1,442
Self-citationThe Pediatric Anxiety Rating Scale (PARS): development and psychometric properties
P, T. R. U. O. P. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200209000-00006 · Cited by 532
How Placebos Change the Patient's Brain
Benedetti, F., Carlino, E., & Pollo, A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.81 · Cited by 446 · cited 4×
“Such expectations have been associated with a number of cognitive factors, which may be germane to the anxious pediatric patient, including cognitive reassessment with positive expectation, which may result in adaptation of behavior or symptom expression (Benedetti et al. 2011).”
BackgroundInfluentialClinical characteristics of anxiety disordered youth
Kendall, P. C., Compton, S. N., Walkup, J. T., Birmaher, B., Albano, A. M., Sherrill, J., Ginsburg, G., Rynn, M., McCracken, J., Gosch, E., et al. (2010) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2010.01.009 · Cited by 369 · cited 2×
“2010) as have baseline characteristics of the patients (Kendall et al. 2010) and acute (Walkup et al.”
MethodResultSelf-citationBridge, J. A., Birmaher, B., Iyengar, S., Barbe, R. P., & Brent, D. A. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08020247 · Cited by 256 · cited 4×
“However, few studies have evaluated PBO response specifically in pediatric patients (Bridge et al. 2009; Cohen et al. 2010; Dobson and Strawn 2016) and most of these evaluations have focused on trial-level factors (e.g., number of study sites, total number of subjects, randomization pattern,…”
BackgroundInfluentialSelf-citationCompton, S. N., Peris, T. S., Almirall, D., Birmaher, B., Sherrill, J., Kendall, P. C., March, J. S., Gosch, E. A., Ginsburg, G. S., Rynn, M. A., et al. (2014) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0035458 · Cited by 226
Self-citationSET-C Versus Fluoxetine in the Treatment of Childhood Social Phobia
BEIDEL, D. C., TURNER, S. M., SALLEE, F. R., AMMERMAN, R. T., CROSBY, L. A., & PATHAK, S. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318154bb57 · Cited by 223
Patient Expectancy as a Mediator of Placebo Effects in Antidepressant Clinical Trials
Rutherford, B. R., Wall, M. M., Brown, P. J., Choo, T.-H., Wager, T. D., Peterson, B. S., Chung, S., Kirsch, I., & Roose, S. P. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16020225 · Cited by 183 · cited 2×
“The expectation of therapeutic benefit has been a focus of prior evaluations of PBO response and has been considered a key factor in PBO response (Benedetti et al. 2011; Rutherford et al. 2017).”
Background
Cited by
Research Review: Pediatric Anxiety Disorders—What Have We Learnt in the Last 10 Years?
Strawn, J. R., Lu, L., Peris, T. S., Levine, A., & Walkup, J. T. (2021) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13262 · Cited by 168
Self-citationStrawn, J. R., Mills, J. A., Sauley, B. A., & Welge, J. A. (2018) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2018.01.015 · Cited by 98
Self-citationStrawn, J. R., Compton, S. N., Robertson, B., Albano, A. M., Hamdani, M., & Rynn, M. A. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2016.0132 · Cited by 55
Self-citation
Metadata
- Authors
- Strawn, J. R., Dobson, E. T., Mills, J. A., Cornwall, G. J., Sakolsky, D., Birmaher, B., Compton, S. N., Piacentini, J., McCracken, J. T., Ginsburg, G. S., Kendall, P. C., Walkup, J. T., Albano, A. M., & Rynn, M. A.
- Venue
- Journal of Child and Adolescent Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2017-08
- Volume
- 27
- Issue
- 6
- Pages
- 501-508
- ISSN
- 1044-5463 (ISSN-L)
- 1557-8992
- OpenAlex
- W2606531459
- Cited by
- 36
- References
- 14
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.